Journey Medical Corporati...

NASDAQ: DERM · Real-Time Price · USD
7.41
-0.13 (-1.72%)
At close: Jun 06, 2025, 3:59 PM
7.39
-0.27%
After-hours: Jun 06, 2025, 04:00 PM EDT

Journey Medical Statistics

Share Statistics

Journey Medical has 23.3M shares outstanding. The number of shares has increased by 4.38% in one year.

23.3M
4.38%
0%
18.41%
n/a
1,007
1.05%

Short Selling Information

The latest short interest is 315.98K, so 1.36% of the outstanding shares have been sold short.

315.98K
1.36%
2.66%
3.12

Valuation Ratios

The PE ratio is -5.44 and the forward PE ratio is 8.6. Journey Medical's PEG ratio is -0.02.

-5.44
8.6
1.42
0.6
3.98
-8.75
-0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Journey Medical.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.25.

1.37
0.96
1.25
-2.99
-2.75
-5.07

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$1,369,121.95
$-357,853.66
41
0.7
1.45

Taxes

61K
-0.42%

Stock Price Statistics

The stock price has increased by 57.66% in the last 52 weeks. The beta is 0.88, so Journey Medical's price volatility has been higher than the market average.

0.88
57.66%
6.88
5.58
53.18
96,007

Income Statement

In the last 12 months, Journey Medical had revenue of 56.13M and earned -14.67M in profits. Earnings per share was -0.72.

56.13M
35.26M
-13.68M
-14.67M
-8.4M
-11.91M
-0.72
Full Income Statement

Balance Sheet

The company has 20.3M in cash and 25.08M in debt, giving a net cash position of -4.78M.

20.3M
25.08M
-4.78M
-87.03M
84.96M
13.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.13M and capital expenditures 0, giving a free cash flow of -9.13M.

-9.13M
n/a
-9.13M
-0.45
Full Cash Flow Statement

Margins

Gross margin is 62.81%, with operating and profit margins of -24.36% and -26.14%.

62.81%
-24.36%
-26.03%
-26.14%
-14.96%
-24.36%
-16.26%

Dividends & Yields

DERM does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for DERM is $10, which is 35% higher than the current price. The consensus rating is "Buy".

$10
35%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

0.89
3